Immune Monitor - August 2021

A Message from the President

Dear Colleagues,

I can’t believe that six months have already elapsed since my very first fireside chat. Back in February, I spoke to BioNTech CEO Ugur Sahin, MD, about the pandemic and the process to achieving a highly effective SARS-CoV-2 vaccine. While the world still grapples with the COVID-19 pandemic, the vaccines have undeniably played a huge role in drastically decreasing the hospitalization and death rates caused by the virus, in locations where the vaccines are available and highly utilized.
 
The pandemic disrupted all facets of life – personal and professional – as we all know, however, work in the lab and clinic to improve cancer patient outcomes still continued. To discuss the state of cancer immunotherapy research in 2021 and its future, I thought there could be few guests more appropriate than Elizabeth Jaffee, MD, the Deputy Director of Johns Hopkins Kimmel Cancer Center in Baltimore, Md.


Dr. Jaffee served as a keynote presenter during our society’s entirely virtual 35th Anniversary Annual Meeting last fall and she co-lead an AACR-SITC workshop on toxicities in March 2020 when news began to break of shutdowns in the country due to COVID. The work continued coming out of the workshop, despite the raging pandemic, which we talked about, among many other issues, for my latest SITC fireside chat. I’d like to share that the manuscript to come out of the toxicities workshop has been accepted for publication in the Journal for ImmunoTherapy of Cancer (JITC), so stay tuned in the coming weeks for a link to view this important work.

Dr. Jaffee has been a hugely important leader to our society, as both a rock star in pancreatic cancer research and in general as a leading woman in the field. I particularly enjoyed our conversation on mentorship in the field, and I hope viewers of all experience levels really valued her words of wisdom as we train the next generation in the SITC family to become leaders in their own right. Please click here to view the video on the SITC YouTube channel.

Thanks to Dr. Jaffee once again for joining me this month! I look forward to seeing  her, and the rest of you, at the 36th Annual Meeting & Pre-Conference Programs (SITC 2021) this November in Washington, D.C.

Sincerely,


Patrick Hwu, MD

SITC President

Applications to Attend Clinical Trial Protocol Development Workshop Due Friday

Apply by Friday at 11:59 p.m. EDT to attend SITC’s new Clinical Immuno-Oncology Network (SCION) Workshop, taking place Jan. 23–28, 2022, in Austin, Texas, at the AT&T Hotel and Conference Center. Selected participants will develop a full cancer immunotherapy clinical trial protocol through small-group work with guidance from expert faculty during the five-day program.
Upon acceptance into the program, SCION Workshop applicants will be required to register for SITC's fourth annual Cancer Immunotherapy Winter School. Applications are due by Friday, Aug. 6, 2021, at 11:59 p.m. EDT.

Register Today To Attend SITC 2021 in November

Registration is now open for the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021)! SITC 2021 takes place Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Click here to register.

For more information about attending SITC 2021 in person and virtually, visit the FAQ page.

Important Dates

SITC is also accepting abstracts through July 22 for two additional programs. See below for more information about the Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop and the Cytokines in Cancer Immunotherapy Workshop.

Exhibiting and Sponsorship

SITC offers a number of ways to promote your product or service. SITC 2021 will be presented as a hybrid meeting, which means we have innovative in-person and virtual solutions to meet your marketing and branding needs.

Contact development@sitcancer.org or (414) 271-2456 for more information and to discuss customization options.

    Register Now for SITC Fall Programs

    Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop

    Sept. 29–30, 2021 · San Diego · Register Now · Program Schedule                                                     

    Program Organizers

    • Samir M. Hanash, MD, PhD  – The University of Texas MD Anderson
    • Avery D. Posey Jr., PhD – University of Pennsylvania School of Medicine

    Bispecific T cell Engagers Workshop

    Sept. 30–Oct. 1, 2021 · San Diego · Register Now· Program Schedule

    Program Organizers

    • Elizabeth Budde, MD, PhD – City of Hope
    • Daniel S. Chen, MD, PhD – IGM Biosciences, Inc.
    • James L. Gulley, MD, PhD, FACP – National Cancer Institute

    Cytokines in Cancer Immunotherapy Workshop

    Oct. 11–12, 2021 · New York · Register Now · Program Schedule

    Program Organizers

    • Susan M. Kaech, PhD – Salk Institute
    • Anne O' Garra, PhD – The Francis Crick Institute
    • Aaron Ring, MD, PhD– Yale University